Evaluation of the effect of Interferon Alfa-2b in diabetic macular edema
Phase 2
Recruiting
- Conditions
- Diabetic macular edema.unspecified diabetic retinopathy with macular edemaE11. 311
- Registration Number
- IRCT20230103057035N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
Diabetic patients over 18 years old
Macular edema involving the center.
BCVA between 20/400-40/20
Central macular thickness greater than or equal to 300 µm
Requires 3 IVB injections in the next 12 weeks
Retinal clarity, pupillary dilation for OCT, and necessary cooperation for proper fundus photography
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease thickness of the central part of the macula. Timepoint: At the beginning of the study and one month after the third injection of bevacizumab. Method of measurement: Oct device (Optical coherence tomography).
- Secondary Outcome Measures
Name Time Method Improve visual acuity. Timepoint: Before the study and one month after the third injection of bevacizumab. Method of measurement: Optometry.